<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37061283</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2173-5743</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Reumatologia clinica</Title><ISOAbbreviation>Reumatol Clin (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Lupus anticoagulant-hypoprothrombinemia syndrome: A cerebral bleeding case report as systemic lupus erythematosus debut.</ArticleTitle><Pagination><StartPage>223</StartPage><EndPage>227</EndPage><MedlinePgn>223-227</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.reumae.2022.02.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2173-5743(23)00036-9</ELocationID><Abstract><AbstractText>Lupus anticoagulant-hypoprothrombinaemia syndrome (LAHPS) is a rare disorder caused by the presence of lupus anticoagulant (LA) and acquired prothrombin deficiency, which may present with severe haemorrhagic manifestations. LAHPS is usually associated with systemic lupus erythematosus (SLE), or infections and it is more frequent in the paediatric population and female gender. We describe a 42-year-old man with thrombotic antiphospholipid syndrome (APS) on chronic anticoagulation treatment with acenocoumarol who presented with spontaneous intracranial bleeding, prolongation of prothrombin time (PT), activated partial thromboplastin time (APTT) and low factor II levels (after optimal anticoagulation reversal) as a debut of SLE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Espa&#xf1;a, S.L.U. and Sociedad Espa&#xf1;ola de Reumatolog&#xed;a y Colegio Mexicano de Reumatolog&#xed;a. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>P&#xe9;rez</LastName><ForeName>Miriam Lopez</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Hematology, Hospital Universitario Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az, Hospitales Quir&#xf3;n P&#xfa;blicos, IIS-FJD, Madrid, Spain. Electronic address: Miriam.lopez@hospitalreyjuancarlos.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laso</LastName><ForeName>Rosa Vidal</ForeName><Initials>RV</Initials><AffiliationInfo><Affiliation>Department of Hematology, Hospital Universitario Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az, Hospitales Quir&#xf3;n P&#xfa;blicos, IIS-FJD, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velasco-Rodr&#xed;guez</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Hematology, Hospital Universitario Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az, Hospitales Quir&#xf3;n P&#xfa;blicos, IIS-FJD, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n-Herrero</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Hematology, Hospital Universitario Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az, Hospitales Quir&#xf3;n P&#xfa;blicos, IIS-FJD, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfonzo</LastName><ForeName>In&#xe9;s Martinez</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Department of Hematology, Hospital Universitario Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az, Hospitales Quir&#xf3;n P&#xfa;blicos, IIS-FJD, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Raso</LastName><ForeName>Ar&#xe1;nzazu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Hematology, Hospital Universitario Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az, Hospitales Quir&#xf3;n P&#xfa;blicos, IIS-FJD, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llamas-Sillero</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Hematology, Hospital Universitario Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az, Hospitales Quir&#xf3;n P&#xfa;blicos, IIS-FJD, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Reumatol Clin (Engl Ed)</MedlineTA><NlmUniqueID>101717526</NlmUniqueID><ISSNLinking>2173-5743</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016682">Lupus Coagulation Inhibitor</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-26-7</RegistryNumber><NameOfSubstance UI="D011516">Prothrombin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016736" MajorTopicYN="Y">Antiphospholipid Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016682" MajorTopicYN="N">Lupus Coagulation Inhibitor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007020" MajorTopicYN="Y">Hypoprothrombinemias</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011516" MajorTopicYN="N">Prothrombin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adult</Keyword><Keyword MajorTopicYN="N">Adulto</Keyword><Keyword MajorTopicYN="N">Hipoprotrombinemia</Keyword><Keyword MajorTopicYN="N">Hypoprothrombinaemia</Keyword><Keyword MajorTopicYN="N">Inhibidor de la coagulaci&#xf3;n l&#xfa;pica</Keyword><Keyword MajorTopicYN="N">Lupus anticoagulant-hypoprothrombinaemia syndrome</Keyword><Keyword MajorTopicYN="N">Lupus coagulation inhibitor</Keyword><Keyword MajorTopicYN="N">Lupus eritematoso sist&#xe9;mico</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">S&#xed;ndrome de anticoagulante l&#xfa;pico-hipoprotrombinemia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>10</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>15</Day><Hour>20</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37061283</ArticleId><ArticleId IdType="doi">10.1016/j.reumae.2022.02.008</ArticleId><ArticleId IdType="pii">S2173-5743(23)00036-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>